Acción 605033 SHAANXI MEIBANG PHARMACEUTICAL GROUP CO., LTD.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Shaanxi Meibang Pharmaceutical Group Co., Ltd.

Acciones

605033

CNE100005071

Precio de cierre Shanghai S.E.
Otros sitios de cotización
 00:00:00 15/07/2024 		Varia. Cinco días. Varia. 1 de enero.
11,76 CNY -3,13 % Gráfico intradía de Shaanxi Meibang Pharmaceutical Group Co., Ltd. +0,86 % -34,48 %
29/04 Shaanxi Meibang Pharmaceutical Group Co. Resultados del primer trimestre finalizado el 31 de marzo de 2024 CI
25/04 Shaanxi Meibang Pharmaceutical Group Co. Resultados del ejercicio cerrado el 31 de diciembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Meibang Pharmaceutical Earmarks 1.4 Billion Yuan for Factory Construction
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Shaanxi Yatai Testing and Evaluation Co., Ltd. announced that it has received CNY 25 million in funding from Shaanxi Meibang Pharmaceutical Group Co., Ltd.
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Shaanxi Yatai Testing and Evaluation Co., Ltd. announced that it expects to receive CNY 25 million in funding from Shaanxi Meibang Pharmaceutical Group Co., Ltd.
Shaanxi Meibang Pharma Unit Buys 35.3 Million Yuan Land For Pesticide and Fertilizer Plant
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Shaanxi Meibang Pharmaceutical Group Co., Ltd.(SHSE:605033) added to Shanghai Stock Exchange Composite Index
Shaanxi Meibang Pharmaceutical Group Co., Ltd.(SHSE:605033) added to Shanghai Stock Exchange A Share Index
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Shaanxi Meibang Pharmaceutical Group Co., Ltd. has completed an IPO in the amount of CNY 428.922 million.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 605033
  4. Noticias Shaanxi Meibang Pharmaceutical Group Co., Ltd.
  5. Otros idiomas